Background Despite advances in the medical management of secondary
hyperparathyroidism due to chronic renal failure and dialysis (renal hyperparathyroidism) …

Background A significant proportion of patients with chronic kidney disease and secondary
hyperparathyroidism (HPT) remain hyperparathyroid after kidney transplantation, a state …

These guidelines cover the care of patients from the period following kidney transplantation
until the transplant is no longer working or the patient dies. During the early phase …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism. Background …

In patients with end-stage renal disease, successful renal transplantation improves the
quality of life and increases survival, as compared with long-term dialysis treatment …

Secondary and tertiary hyperparathyroidism (HPT) develop in patients with renal failure due
to a variety of mechanisms including increased phosphorus and fibroblast growth factor 23 …

Kidney transplantation, the most effective treatment for the metabolic abnormalities of
chronic kidney disease (CKD), only partially corrects CKD–mineral and bone disorders …

Objective Analyze the efficacy and indications for parathyroidectomy as an intervention for
tertiary hyperparathyroidism. Data sources PubMed, MEDLINE, and Cochrane Library …

Objectives: Due to the paucity of data and controversy regarding the preferred surgical
approach for managing tertiary HPT, we sought to investigate the outcomes of different …

Background Tertiary hyperparathyroidism occurs in 25% to 50% of kidney-transplanted
patients. Indication of parathyroidectomy is now discussed, since the calcimimetic agent …